The FDA has approved Tryptyr (acoltremon) as the first TRPM8-targeting eye drop for dry eye disease, stimulating natural tear ...

Spun off from Novartis in 2019, Alcon is betting on new product launches to accelerate sales growth in the second half of ...

Alcon, a global eye care company known for products such as Systane and GenTeal Tears, plans to launch Tryptyr in the U.S.

Millions of Americans suffer from dry eye disease, an often-overlooked condition that can significantly impact daily life. In ...

The FDA approved Tryptyr to treat the signs and symptoms of dry eye disease, according to a press release from Alcon. Tryptyr ...

Alcon Announces FDA Approval of TRYPTYR (acoltremon ophthalmic solution) 0.003% for the Treatment of the Signs and Symptoms ...

In this episode of CT BUZZ, Reporter Jillian Andrews sat down with Dr. Donald Higgins, Optometrist and Medical Director of ...

The US FDA approves Alcon's dry-eye drug, China bans Brazilian poultry imports due to avian influenza, and various lawsuits ...

The active ingredient in Tryptyr is acoltremon, an agonist of transient receptor potential melastatin 8 thermoreceptors.

Dry eye syndrome, a condition affecting millions of Americans each year, continues to present a frustrating challenge for ...

Tear film stability, tear production, ocular surface health, and symptoms were all significantly improved with the use of ...

Are you one of the millions dealing with dry eye syndrome? FOX 26 senior legal analyst Chris Tritico talks about his dry eye ...